Friesen C - Search Results

1

Friesen C, Hormann I, Roscher M, Bacher S, Miltner E. Friesen C, et al. Nuklearmedizin. 2010;49 Suppl 1:S31-6. Nuklearmedizin. 2010. PMID: 21152691 German.

2

Cytotoxic effects of opioids on cancer cell lines.

Friesen C, Bacher S, Hormann I, Roscher M, Miltner E. Friesen C, et al. Int J Clin Pharmacol Ther. 2011 Jan;49(1):60-2. Int J Clin Pharmacol Ther. 2011. PMID: 21176729 No abstract available.

3

Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance.

Friesen C, Roscher M, Alt A, Miltner E. Friesen C, et al. Cancer Res. 2008 Aug 1;68(15):6059-64. doi: 10.1158/0008-5472.CAN-08-1227. Cancer Res. 2008. PMID: 18676827

4

Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells.

Roscher M, Hormann I, Leib O, Marx S, Moreno J, Miltner E, Friesen C. Roscher M, et al. Among authors: friesen c. Oncotarget. 2013 Feb;4(2):218-30. doi: 10.18632/oncotarget.817. Oncotarget. 2013. PMID: 23474846 Free PMC article.

5

Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large.

Friesen C, Roscher M, Hormann I, Leib O, Marx S, Moreno J, Miltner E. Friesen C, et al. Eur J Cancer. 2013 Jul;49(11):2542-54. doi: 10.1016/j.ejca.2013.04.008. Epub 2013 May 16. Eur J Cancer. 2013. PMID: 23684782

6

Cell death sensitization of leukemia cells by opioid receptor activation.

Friesen C, Roscher M, Hormann I, Fichtner I, Alt A, Hilger RA, Debatin KM, Miltner E. Friesen C, et al. Oncotarget. 2013 May;4(5):677-90. doi: 10.18632/oncotarget.952. Oncotarget. 2013. PMID: 23633472 Free PMC article.

7

DNA-ligase IV and DNA-protein kinase play a critical role in deficient caspases activation in apoptosis-resistant cancer cells by using doxorubicin.

Friesen C, Uhl M, Pannicke U, Schwarz K, Miltner E, Debatin KM. Friesen C, et al. Mol Biol Cell. 2008 Aug;19(8):3283-9. doi: 10.1091/mbc.e08-03-0306. Epub 2008 May 28. Mol Biol Cell. 2008. PMID: 18508926 Free PMC article.

8

Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.

Friesen C, Hormann I, Roscher M, Fichtner I, Alt A, Hilger R, Debatin KM, Miltner E. Friesen C, et al. Cell Cycle. 2014;13(10):1560-70. doi: 10.4161/cc.28493. Epub 2014 Mar 12. Cell Cycle. 2014. PMID: 24626197 Free PMC article.

9

123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.

Reske SN, Deisenhofer S, Glatting G, Zlatopolskiy BD, Morgenroth A, Vogg AT, Buck AK, Friesen C. Reske SN, et al. Among authors: friesen c. J Nucl Med. 2007 Jun;48(6):1000-7. doi: 10.2967/jnumed.107.040337. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504875 Free article.

10

Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells.

Friesen C, Glatting G, Koop B, Schwarz K, Morgenstern A, Apostolidis C, Debatin KM, Reske SN. Friesen C, et al. Cancer Res. 2007 Mar 1;67(5):1950-8. doi: 10.1158/0008-5472.CAN-06-3569. Cancer Res. 2007. PMID: 17332322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page